Signing on the spot about 12 billion yuan 2022 Shenzhen Biomedical China Merchants Conference opened

Reading Client · Shenzhen News Network, July 28, 2022 (Reporter Yuan Zheng, one) On the morning of July 28, the 2022 Shenzhen Biomedical Merchants Conference opened at the Shenzhen Convention and Exhibition Center of Yanzi Lake, Pingshan, Shenzhen.

The China Merchants Conference invited more than 100 representatives of biomedical enterprises at home and abroad, Shenzhen key enterprises, and representatives of biomedical enterprises interested in deep investment, experts and scholars in the biomedical industry, Shenzhen departments, and districts. The Shenzhen biopharmaceutical industry planning and policy system was explained and interpreted on the key support direction and policies and measures of Shenzhen's biomedical industry.

(Photo of Shenzhen Development and Reform Commission)

At the event, the Shenzhen Da Health Industry Alliance was unveiled. It is reported that as the first batch of national biomedical industry bases and national independent innovation demonstration zones, Shenzhen was the first to include biology into emerging industries as early as 2009. After more than ten years of cultivation, the added value of the biological and health industry in 2021 reached 58.96 billion yuan, which initially formed two major industrial agglomeration areas, Nanshan High -tech Zone and Pingshan National Biological Industry Base.

Since June 2022, Shenzhen has introduced a series of documents on the development of strategic emerging industrial clusters and cultivating the development of future industries, including the action plan of biomedical, high -end medical equipment, and large healthy industrial clusters, and promoting high -quality development of industrial clusters Several measures, etc., launch a series of supporting policies and measures in major public service platform construction, core technology research, special park construction, product application demonstration, financial support strengthening, industrial land guarantee, talent introduction and cultivation and cultivation.

(Photo of Shenzhen Development and Reform Commission)

At the meeting, I intended to come to the representative of the deep investment biomedical companies, Tian Yuan, the chairman of Mai Sheng Group, and Wang Feng, the president of Shanghai Lechun Biological Bio, who entrepreneurially entrepreneurially entrepreneurially entrepreneurially entrepreneurially issued a special speech on behalf of the unknown biological co -founder of Shenzhen. Shenzhen biopharmaceutical industry strategic planning, biopharmaceutical industry support policies, innovation and entrepreneurial business environment, government investment promotion services, etc. expressed their personal experience and expectations.

Relevant leaders of the Shenzhen Development and Reform Commission preach to the Shenzhen Biological and Health Industry Cluster Plan and Support Policy. According to reports, according to the cluster development goals, by 2025, Shenzhen will strive to become a leading and international -level biological and healthy industry agglomeration development highland in China. 65 billion yuan, the value -added of the big health industry reached 30 billion yuan. In terms of support policies, the maximum funding for industrialized projects is 15 million yuan, and the national public service platforms are supported by 1: 1, core technology research and major industrial projects have a maximum funding of 300 million yuan.

At the same time, the signing ceremony of Shenzhen Biomedical Industry Investment in key projects was held. It is understood that a total of 18 companies signed a contract at the scene, with a total amount of about 12 billion yuan.

(Photo of Shenzhen Development and Reform Commission)

- END -